Announcement didn't make any difference to the share price, which says it all, really. No value is typically assigned to preclinical compounds, and this hasn't even reached the preclinical stage. So it's a "at least we haven't been sitting on our arses" announcement, but it hardly means anything to the bottom line.
We're headed lower in the short-term. It's probably still overvalued at 20 cents.
another great ann, page-2
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $933.2M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 370000 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 89756 | 2 |
View Market Depth
| Last trade - 16.12pm 21/10/2024 (20 minute delay) ? |
| PYC (ASX) Chart |
Day chart unavailable